A Treatment Protocol for the Use of Intravenous Ganciclovir in AIDS Patients With Immediately Sight-Threatening CMV Retinitis

NCT00000698 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Cytomegalovirus Retinitis
HIV Infections

Interventions

DRUG: Ganciclovir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)